Table 2. In Vitro Antitrypanosomal Evaluation of 3-Chloro-4-(dimethylamino)phenyl-2-thiohydantoin Derivatives (SAR of R3–R4).
compd | R3 | R4 | T.brucei EC50 (nM)a |
---|---|---|---|
1 | H | H | 346 |
38 | 4-Cl | H | 853 |
39 | 4-F | H | 52 |
40 | 3-F | H | 968 |
41 | 4-Me | H | 1553 |
42 | 4-OMe | H | >20000 |
43 | 4-CF3 | H | >20000 |
44 | 4-CN | H | 17818 |
45 | 4–C(O)OEt | H | >20000 |
46 | 3-pyridyl | H | 3000 |
47 | 4-F | 3-F | 313 |
48 | 4-F | 2-F | 63 |
49 | 5-F | 2-F | 9260 |
50 | 4-F | 3-CN | >20000 |
51 | 4-F | 2-Cl | 46 |
52 | 4-F | 2-OMe | 191 |
53 | 4-F | 2-NO2 | 350 |
54 | 4-F | 2-CF3 | 924 |
Concentration of compounds required to inhibit growth by 50% (EC50) of T. brucei brucei strain BF427. Pentamidine isethionate was included as a control for all of the T. brucei EC50 assays with average ± SEM: 1.15 ± 0.09 nM (n = 32).